Investment
Features
FeesSafety
Academy
More
Pluang+

Compare AstraZeneca plc (AZN) vs Unilever plc (UL) Price & Performance

AstraZeneca plcTrade
Unilever plcTrade

Price performance (Past 24H)

Key statistics

AstraZeneca plc vs Unilever plc — how do they compare? AstraZeneca plc trades at $158.19 (market cap $248.14B), while Unilever plc trades at $61.89 (market cap $134.06B). The key difference: AstraZeneca plc is the larger of the two by market cap, and Unilever plc pays the higher dividend (3.65%). Which is the better fit depends on your goals.

AZNUL
Market Cap
$248.14B$134.06B
Sector
HealthConsumer Staples
52-Week High
$209.48$74.59
52-Week Low
$147.06$55.05
Enterprise Value
$275.41B$159.86B
Dividend Yield
2.01%3.65%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About AstraZeneca plc

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.

Read more on AZN

About Unilever plc

Unilever is a diversified personal product (42% of 2021 sales by value), home care (20%), and packaged food (38%) company. Its brands include Knorr soups and sauces, Hellmann's mayonnaise, Lipton teas, Axe and Dove skin products, and the TRESemme haircare brand. The firm has been acquisitive in recent years

Read more on UL